stars 1 stars 2 stars 3

Biois is the manufacturer of Aptamer screening kit (In Vitro Diagnostic Multivariate Index Assay) to diagnose chronic degenerative diseases using a patented technology. Our main products, Bio-Sign is consisting of Bio-Chip and CDSS program (Clinical Decision Support System) and it is enable early screening and analysis of cardiovascular disease, including cancer. Also, our patented technology, Reverse-SELEX, can be applied to the field of basic research of screening bio-markers and drug delivery system. Our final goal is to consistently provide the best diagnostic products through research and development, for healthy living of mankind.

Biois Questions

The Biois annual revenue was $3 million in 2026.

3 people are employed at Biois.

Biois is based in Seoul, Seoul.

The NAICS codes for Biois are [541, 541713, 54171, 54, 5417].

The SIC codes for Biois are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users